Tabuniag, Roselle .
HRN: 25-07-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2024
CEFUROXIME 500MG (TAB)
07/14/2024
07/20/2024
PO
500mg
BID
S/P RMLE With Repair
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes